In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...
Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common ...
Keytruda plus platinum-based chemotherapy was found to be both safe and efficacious in treating penile squamous cell carcinoma (PSCC), according to findings from the phase 2 HERCULES trial presented ...
News-Medical.Net on MSN
Chemotherapy-based conditioning matches outcomes of total body irradiation for MRD-negative B-ALL
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
A new review in Chinese Medical Journal details progress in nanocarrier-based cancer therapy. It analyzes polymeric, lipidic, ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
News-Medical.Net on MSN
Many families of children with leukemia face significant financial hardship during treatment
Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL) – the most common ...
Dr. Cooper is an associate professor of public health and economics at Yale. The debate over whether to extend the expanded ...
Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...
Experts at SICP 2025 outline how molecular mechanisms and bedside assessments can guide personalised treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback